Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Kodiak Sciences Inc.
Report date April 02, 2020 · Filed April 07, 2020
Section 16 reporting ended · disclosed 2020-04-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 130,166 |
Reported balance
After 2020-04-02 transaction · row 1
1 source rowRow 1 · 2020-04-02 · Sale · Disposed 4,000 · Balance 130,166 F1: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F2: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $41.97 to $42.71, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.
F2: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $41.97 to $42.71, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 02, 2020 Filed Apr 7, 2020 00:08 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 4,000 | $42.34 | $169,360.00 |
DisclosureSEC source: 0001209191-20-023673 · doc4.xml · nonDerivative · entry 1 Liang Hong · CIK 0001754627 · SVP, Discovery Medicine 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,166 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $41.97 to $42.71, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 26, 2020 Filed Mar 30, 2020 20:51 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 352 | $49.00 | $17,248.00 |
DisclosureSEC source: 0001209191-20-021727 · doc4.xml · nonDerivative · entry 3 Liang Hong · CIK 0001754627 · SVP, Discovery Medicine 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,166 F1 · kind: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan. Read SEC document |
| March 26, 2020 Filed Mar 30, 2020 20:51 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,103 | $48.53 | $53,533.88 |
DisclosureSEC source: 0001209191-20-021727 · doc4.xml · nonDerivative · entry 2 Liang Hong · CIK 0001754627 · SVP, Discovery Medicine 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,518 F1 · kind: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $47.88 to $48.78, inclusive. Read SEC document |
| March 26, 2020 Filed Mar 30, 2020 20:51 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 2,545 | $47.28 | $120,330.15 |
DisclosureSEC source: 0001209191-20-021727 · doc4.xml · nonDerivative · entry 1 Liang Hong · CIK 0001754627 · SVP, Discovery Medicine 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,621 F1 · kind: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $46.84 to $47.84, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 20:36 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 2,046 | $39.99 | $81,819.54 |
DisclosureSEC source: 0001209191-20-020648 · doc4.xml · nonDerivative · entry 2 Liang Hong · CIK 0001754627 · SVP, Discovery Medicine 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,166 F1 · kind: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $39.77 to $40.12, inclusive. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 20:36 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,954 | $38.89 | $75,991.06 |
DisclosureSEC source: 0001209191-20-020648 · doc4.xml · nonDerivative · entry 1 Liang Hong · CIK 0001754627 · SVP, Discovery Medicine 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,212 F1 · kind: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $38.61 to $39.50, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set fort in these footnotes. Read SEC document |
| December 30, 2019 Filed Jan 2, 2020 22:32 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $73.51 | $0.00 |
DisclosureSEC source: 0001209191-20-000404 · doc4.xml · derivative · entry 1 Liang Hong · CIK 0001754627 · SVP, Discovery Medicine 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2029-12-29 F1 · derivative.exercise_date: 1/48th of the shares subject to the option will vest on January 30, 2020, and 1/48th of the shares subject to the option vest on the same day of each month thereafter, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) as of each such date. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 22:33 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,916 | $0.00 Strike: $1.06 | $0.00 |
DisclosureSEC source: 0001209191-19-059119 · doc4.xml · derivative · entry 4 Liang Hong · CIK 0001754627 · SVP, Discovery Medicine 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,084 Underlying: Common Stock · 12,916 shares Expires 2027-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-forty-eighth of the shares subject to the option vested on May 15, 2017, and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 22:33 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 29,250 | $0.00 Strike: $1.04 | $0.00 |
DisclosureSEC source: 0001209191-19-059119 · doc4.xml · derivative · entry 3 Liang Hong · CIK 0001754627 · SVP, Discovery Medicine 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,750 Underlying: Common Stock · 29,250 shares Expires 2026-06-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Twenty-Five percent of the shares subject to the option vested on December 7, 2016, and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 22:33 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 12,916 | $1.06 | $13,690.96 |
DisclosureSEC source: 0001209191-19-059119 · doc4.xml · nonDerivative · entry 2 Liang Hong · CIK 0001754627 · SVP, Discovery Medicine 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 22:33 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 29,250 | $1.04 | $30,420.00 |
DisclosureSEC source: 0001209191-19-059119 · doc4.xml · nonDerivative · entry 1 Liang Hong · CIK 0001754627 · SVP, Discovery Medicine 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 16, 2019 Filed Jul 18, 2019 21:49 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $14.23 | $0.00 |
DisclosureSEC source: 0000899243-19-019935 · doc4.xml · derivative · entry 1 Liang Hong · CIK 0001754627 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2029-07-15 F1 · derivative.exercise_date: One forty-eighth of the shares subject to the option will vest on August 16, 2019, and 1/48th of the shares subject to the option vest on the same day of each month thereafter, subject to the Reporting Person's continuous service as a service provider on each such date. Read SEC document |
| February 07, 2019 Filed Feb 8, 2019 21:15 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $1.04 | $0.00 |
DisclosureSEC source: 0000899243-19-003022 · doc4.xml · derivative · entry 2 Liang Hong · CIK 0001754627 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 80,000 shares Expires 2026-06-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Reporting Person was originally granted an option to purchase 132,000 shares. Twenty-Five percent of the shares subject to the option vested on December 7, 2016, and 1/48th of the shares subject to the option vest on the same day of each month thereafter. On August 30, 2018, the Reporting Person exercised 20,000 of those shares and on February 7, 2019, the Reporting Person exercised 80,000 of those shares. Read SEC document |
| February 07, 2019 Filed Feb 8, 2019 21:15 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 80,000 | $1.04 | $83,200.00 |
DisclosureSEC source: 0000899243-19-003022 · doc4.xml · nonDerivative · entry 1 Liang Hong · CIK 0001754627 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person entered into a Lock-up Agreement in favor of the underwriters of the Company's initial public offering in October 2018 (the "Lock-up"). The terms of the Lock-up permit the exercise of options by the Reporting Person for cash and the shares of common stock issued as a result of the exercise are subject to the terms of the Lock-up. No shares of common stock were sold by the Reporting Person in connection with the exercise. Read SEC document |
| October 03, 2018 Filed Oct 5, 2018 21:32 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantStock Option (Right to Buy) · Derivative | 69,820 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0000899243-18-026321 · doc4.xml · derivative · entry 1 Liang Hong · CIK 0001754627 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,820 Underlying: Common Stock · 69,820 shares Expires 2028-10-02 F1 · derivative.exercise_date: One-sixtieth of the shares subject to the option will vest on November 3, 2018, and 1/60th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.